Literature DB >> 11994497

Transforming growth factor beta signal transduction.

Sylviane Dennler1, Marie-José Goumans, Peter ten Dijke.   

Abstract

Transforming growth factor beta1 (TGF-beta1) is the prototypic member of a large family of structurally related pleiotropic-secreted cytokines that play a pivotal role in the control of differentiation, proliferation, and state of activation of many different cell types including immune cells. TGF-beta family members have potent immunosuppressor activities in vitro and in vivo. These cytokines trigger their biological effects by inducing the formation of a heteromeric transmembrane serine/threonine kinase receptor complex. These receptors then initiate intracellular signaling through activation of Smad proteins, and specific Smads become phosphorylated and associate with other Smads. These heteromeric Smad complexes accumulate in the nucleus, where they modulate the expression of target genes. Recent data support the notion that Smads are important intracellular effectors of TGF-beta in immune cells. Here, we review recent advances in TGF-beta signal transduction in immune cells.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11994497

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  75 in total

1.  Structures of an ActRIIB:activin A complex reveal a novel binding mode for TGF-beta ligand:receptor interactions.

Authors:  Thomas B Thompson; Teresa K Woodruff; Theodore S Jardetzky
Journal:  EMBO J       Date:  2003-04-01       Impact factor: 11.598

2.  Smad6 recruits transcription corepressor CtBP to repress bone morphogenetic protein-induced transcription.

Authors:  Xia Lin; Yao-Yun Liang; Baohua Sun; Min Liang; Yujiang Shi; F Charles Brunicardi; Yang Shi; Xin-Hua Feng
Journal:  Mol Cell Biol       Date:  2003-12       Impact factor: 4.272

3.  Redirection of B cell responsiveness by transforming growth factor beta receptor.

Authors:  Jurgen Roes; B Ken Choi; Balthazar B Cazac
Journal:  Proc Natl Acad Sci U S A       Date:  2003-05-28       Impact factor: 11.205

Review 4.  Cardiac cell therapy: boosting mesenchymal stem cells effects.

Authors:  E Samper; A Diez-Juan; J A Montero; P Sepúlveda
Journal:  Stem Cell Rev Rep       Date:  2013-06       Impact factor: 5.739

5.  Interactions of DPP-4 and integrin β1 influences endothelial-to-mesenchymal transition.

Authors:  Sen Shi; Swayam Prakash Srivastava; Megumi Kanasaki; Jianhua He; Munehiro Kitada; Takako Nagai; Kyoko Nitta; Susumu Takagi; Keizo Kanasaki; Daisuke Koya
Journal:  Kidney Int       Date:  2015-04-01       Impact factor: 10.612

6.  Bioluminescence imaging of Smad signaling in living mice shows correlation with excitotoxic neurodegeneration.

Authors:  Jian Luo; Amy H Lin; Eliezer Masliah; Tony Wyss-Coray
Journal:  Proc Natl Acad Sci U S A       Date:  2006-11-16       Impact factor: 11.205

Review 7.  Complexity in interpretation of embryonic epithelial-mesenchymal transition in response to transforming growth factor-beta signaling.

Authors:  Shaheen Ahmed; Ali Nawshad
Journal:  Cells Tissues Organs       Date:  2007       Impact factor: 2.481

8.  Ischaemia-reperfusion modulates inflammation and fibrosis of skeletal muscle after contusion injury.

Authors:  Ahmed Ghaly; Daniel R Marsh
Journal:  Int J Exp Pathol       Date:  2010-03-26       Impact factor: 1.925

9.  Chronically increased transforming growth factor-beta1 strongly inhibits hippocampal neurogenesis in aged mice.

Authors:  Marion S Buckwalter; Makiko Yamane; Bronwen S Coleman; Brandi K Ormerod; Jocelyn T Chin; Theo Palmer; Tony Wyss-Coray
Journal:  Am J Pathol       Date:  2006-07       Impact factor: 4.307

10.  Development of antisense oligonucleotide (ASO) technology against Tgf-β signaling to prevent scarring during flexor tendon repair.

Authors:  Alayna E Loiselle; Kiminori Yukata; Michael B Geary; Sirish Kondabolu; Shanshan Shi; Jennifer H Jonason; Hani A Awad; Regis J O'Keefe
Journal:  J Orthop Res       Date:  2015-06       Impact factor: 3.494

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.